David Geller
Los Angeles, CANPI 1154350528
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,799 of the $15,812 with a category attached, or 62.0%. 11 manufacturers reported payments, led by Ascendis Pharma Endocrinology Inc at 52.2% of the total. 2025 is the largest year on record at $8,970, more than ten times the $40 reported in 2021.
Across 30 payments — averaging $527.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$8K
- Pfizer$7K
- Tolmar, Inc.$341
- Novo Nordisk$125
- AbbVie$64
- Neurocrine Biosciences, Inc.$29
- plus $118 from 5 others
Across 6 payments — averaging $54,616 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$328K
What the payments were for
- Consulting fees$3,95025%
- Speaking & faculty fees$9,79962%
- Travel & lodging$1,0397%
- Food & beverage$1,0246%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 3 | $8,250 |
| Pfizer | 14 | $6,885 |
| Tolmar, Inc. | 3 | $341 |
| Novo Nordisk | 1 | $125 |
| AbbVie | 3 | $64 |
| Neurocrine Biosciences, Inc. | 1 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| Medtronic | 1 | $25 |
| Ironwood Pharmaceuticals, Inc | 1 | $25 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Zealand Pharma US, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.